Doctor profile · Federal record
Dr. Dina Doolin, D.O.
Family Medicine Physician (CMS: Family Practice) · New Smyrna Beach, FL
- NPI 1356446223
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 27 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
233 N Causeway
New Smyrna Beach, FL 321695239
(386) 957-9850
fax (386) 410-3731
Credentials & registration
- NPI registered
- September 2006 — 20 yrs on file
- Profile last updated
- April 5, 2022
- Year of graduation
- 1999 — 27 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Florida #OS8699
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1356446223. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,690
Distinct HCPCS
10
Medicare allowed
$175,788
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 1,440 | 16 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 653 | 263 | $118 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 323 | 62 | $0 | |
96372 |
Injection of drug or substance under skin or into muscle | 167 | 65 | $14 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 165 | 109 | $80 | |
17110 |
Destruction of skin growth, 1-14 growths | 123 | 78 | $108 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 118 | 118 | $121 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 99 | 22 | $6 | |
J1885 |
Injection, ketorolac tromethamine, per 15 mg | 66 | 22 | $1 | |
17000 |
Destruction of precancer skin growth, 1 growth | 54 | 39 | $55 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 99. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$1,651
Transactions
63
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | 5 | $425.79 | |
| Novo Nordisk Inc | 12 | $305.67 | |
| Amgen Inc. | 10 | $248.56 | |
| ABBVIE INC. | 10 | $150.95 | |
| PFIZER INC. | 7 | $131.87 | |
| AstraZeneca Pharmaceuticals LP | 5 | $80.67 | |
| Mylan Specialty L.P. | 3 | $70.53 | |
| Lilly USA, LLC | 3 | $60.30 | |
| Abbott Laboratories | 2 | $43.89 | |
| Xeris Pharmaceuticals, Inc. | 1 | $23.17 | |
| Alnylam Pharmaceuticals Inc. | 1 | $20.53 | |
| Astellas Pharma US Inc | 1 | $20.00 | |
| CVRx, Inc. | 1 | $19.03 | |
| Exact Sciences Corporation | 1 | $18.65 | |
| Almatica Pharma LLC | 1 | $18.49 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,401
Patients
1,488
Total drug cost
$52,956
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 588 | 130 | $11,621 |
| Levothyroxine Sodium | Generic | 457 | 130 | $5,711 |
| Losartan Potassium | Generic | 372 | 117 | $5,408 |
| Tramadol Hcl | Generic | 331 | 91 | $1,917 |
| Omeprazole | Generic | 325 | 98 | $3,539 |
| Atorvastatin Calcium | Generic | 318 | 106 | $4,202 |
| Rosuvastatin Calcium | Generic | 294 | 92 | $6,666 |
| Amlodipine Besylate | Generic | 280 | 90 | $1,833 |
| Alprazolam | Generic | 258 | 79 | $1,678 |
| Methylprednisolone | Generic | 230 | 158 | $2,024 |
Hospital affiliations
Frequently asked questions
What is Dr. Dina Doolin's medical specialty?
Dr. Dina Doolin practices Family Medicine Physician in New Smyrna Beach, FL.
Where does Dr. Dina Doolin practice?
Dr. Dina Doolin practices at 233 N Causeway, New Smyrna Beach, FL 321695239. Office phone: 3869579850.
What is Dr. Dina Doolin's NPI?
Dr. Dina Doolin's National Provider Identifier (NPI) is 1356446223, issued by NPPES.
Does Dr. Dina Doolin accept Medicare assignment?
Yes. Dr. Dina Doolin accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dina Doolin commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Injection, dexamethasone sodium phosphate, 1 mg (HCPCS J1100). Source: CMS Medicare Physician & Other Practitioners file.